108 results
Page 3 of 6
8-K
EX-99.1
zs3rj02tnnmjg1hsu
1 Jun 21
Results of Operations and Financial Condition
7:36am
8-K
EX-99.1
vzk mgpx9rrhihoxiv
2 Feb 21
Immunovant Announces Voluntary Pause in Clinical Dosing of IMVT-1401
6:52am
S-3
EX-1.2
ddv 0ru25a6v6wo
4 Jan 21
Shelf registration
8:33am
424B3
wri0tq2fsu4l
12 Nov 20
Prospectus supplement
8:32am
424B4
d6l wleldrz
3 Sep 20
Prospectus supplement with pricing info
12:00am
8-K
EX-99.1
0e3xkr6
25 Aug 20
Regulation FD Disclosure
9:07am
DRS
dbifr209 rkrb5
19 Aug 20
Draft registration statement
12:00am
424B3
c2otfwh3 kwt
12 Aug 20
Prospectus supplement
4:28pm
DEFA14A
d8it3c2 rt
9 Jul 20
Additional proxy soliciting materials
4:12pm
DEF 14A
pwsk6c
9 Jul 20
Definitive proxy
4:08pm
424B3
stu280 yi0h2e09wtojk
29 Jun 20
Prospectus supplement
8:39am
10-K
EX-10.3
c6dt00sc07
29 Jun 20
Annual report
8:30am
10-K
gdw17cx
29 Jun 20
Annual report
8:30am